Clinical Trials List
Protocol NumberNo RD.03.SPR.29053
Not yet recruiting
2005-11-01 - 2006-06-15
Phase I
Terminated1
-
Trial Applicant
GALDERMA HONG KONG LIMITED
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Principal Investigator
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
300 participants
